Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real Life: Treatment Response in Patients With Symptoms Due to Gastroesophageal Reflux Disease Either With or Without Esophagitis Treated With Pantoprazole Sodium 40 mg o.d. Over 8 Weeks

NCT00312806 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00312806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00312806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real Life: Treatment Response in Patients With Symptoms Due to Gastroesophageal Reflux Disease Either With or Without Esophagitis Treated With Pantoprazole Sodium 40 mg o.d. Over 8 Weeks
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
July 31, 2007
Enrollment
2,000 (estimated)
Sites
186

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease (gerd)